Brief: Centric Health Qtrly Loss Per Share $0.10
Aug 14 (Reuters) - Centric Health Corp CHH.TO :
* CENTRIC HEALTH REPORTS Q2'18 FINANCIAL RESULTS, ANNOUNCES
NEW
STRATEGIC DIRECTION
* Q2 REVENUE ROSE 1 PERCENT TO C$43.3 MILLION
* QTRLY ADJUSTED EBITDA FROM CONTINUING OPERATIONS DECLINED
30% TO
$3.4 MILLION
* APPOINTMENT OF DAVID MURPHY AS PRESIDENT AND CEO.
* QTRLY LOSS PER SHARE $0.10
* QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nCNWpPt63a
Further company coverage: CHH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024